Yu, Oriana H.Y.

Pioglitazone use and risk of bladder cancer: Population based cohort study

Tuccori, M., Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., & Azoulay, L. (2016) · BMJ

Metabolism, Diabetes, and CancerBladder and Urothelial Cancer Treatments

Cited by 237

The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions

Moiz, A., Filion, K. B., Tsoukas, M. A., Yu, O. H. Y., Peters, T. M., & Eisenberg, M. J. (2025) · EClinicalMedicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 157

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

Simms-Williams, N., Treves, N., Yin, H., Lu, S., Yu, O., Pradhan, R., Renoux, C., Suissa, S., & Azoulay, L. (2024) · BMJ

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 151

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes

Moiz, A., Filion, K. B., Toutounchi, H., Tsoukas, M. A., Yu, O. H. Y., Peters, T. M., & Eisenberg, M. J. (2025) · Annals of Internal Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 149

Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus.

Faillie, J.-L., Yu, O. H., Yin, H., Hillaire-Buys, D., Barkun, A., & Azoulay, L. (2016) · JAMA Internal Medicine

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 134

Glucagon-like peptide 1 receptor agonists and the risk of incident diabetic retinopathy

Douros, A., Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., & Azoulay, L. (2018) · Diabetes Care

Diabetes Treatment and ManagementRetinal Diseases and Treatments

Cited by 70

Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes

Faillie, J., Yin, H., Yu, O. H. Y., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2022) · Clinical Pharmacology & Therapeutics

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 67

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

Shapiro, S. B., Yin, H., Yu, O. H. Y., Rej, S., Suissa, S., & Azoulay, L. (2025) · BMJ

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 49

A systematic review and meta-analysis comparing outcomes between using subcutaneous insulin and continuous insulin infusion in managing adult patients with diabetic ketoacidosis

Alnuaimi, A., Mach, T., Reynier, P., Filion, K. B., Lipes, J., & Yu, O. H. Y. (2024) · BMC Endocrine Disorders

Diabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 9

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes: An Updated Systematic Review

Moiz, A., Filion, K. B., Samuels, A. E., Tsoukas, M. A., Yu, O. H. Y., Peters, T. M., & Eisenberg, M. J. (2026) · Annals of Internal Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 0